Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

6 recalls, newest first

Class I · High risk

WEFUN Capsules 825 mg

Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenafil, an ingredient found in a FDA approved product for the treatment of male sexual enhancement, making this an unapproved drug.

Terminated Chemical / undeclared Hua Da Trading, Inc. dba Wefun Inc. D-1180-2023
Class II · Moderate risk

Isopropyl Alcohol Antiseptic 75%

CGMP deficiencies: Product manufactured at the same site where FDA testing found Presence of methanol in other products.

Terminated Chemical / undeclared Jarman's Midwest Cleaning Systems, Inc. D-0872-2023
Class I · High risk

PrimeZEN Black 6000 capsule

Marketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

Terminated Chemical / undeclared Volt Candy Wholesale Club D-0453-2023

Recalls by year